Clinical Trials
CluePoints Launch Post-COVID Trial Assurance Solution
CluePoints, the premier provider of Risk-Based Quality Management Solutions for clinical trials, has launched a new Post-COVID Trial Assurance Solution as part of its mission to...
Clinical Trials
Tiziana and FHI Clinical work on Phase II intranasal...
Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, neurology, inflammation and infectious diseases, announces that it has signed an agreement...
Clinical Trials
Vectura, Incannex Enter Preclinical Services Agreement
Vectura Group plc, an inhalation CDMO, has signed an agreement with Incannex Healthcare Ltd., an Australian cannabinoid medicines development company, to provide preclinical development services...
Clinical Trials
Phesi data show clinical trial suspensions continue to rise...
Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back following...
Clinical Trials
Q2 Solutions and Tasso Collaborate to Provide Unique Solutions...
Q2 Solutions, a wholly-owned subsidiary of IQVIA and a leading clinical trial laboratory services organization, announced a transformative collaboration with Tasso Inc., a pioneer in...
Clinical Trials
INOVIO Expands Partnership with Advaccine to Conduct Global Phase...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,...
Clinical Trials
Innovation Pharma Completes Enrollment in Phase 2 Clinical Trial...
Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, announced that it has achieved full patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 clinical trial of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.